Cravens & Co Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Cravens & Co Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cravens & Co Advisors from 13F filings

Historical chart of Cravens & Co Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cravens & Co Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cravens & Co Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0M 2.2k 465.08
2024-06-30 $1.1M 2.3k 468.72

More positions owned by Cravens & Co Advisors

Smartfinancial Com New (SMBK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Doubleline Etf Trust Opportunistic Bd (DBND)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Ishares Tr TRS FLT RT BD (TFLO)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Blackstone Group Inc Com Cl A (BX)
Chevron Corporation (CVX)

View all positions for Cravens & Co Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated